Private Markets: Progress Made Possible
With a unique business model built on reusable shippers and unmatched reverse logistics services, AeroSafe provides biopharma partners with hassle-free sustainable solutions to safely deliver their temperature-sensitive products, significantly reducing the amount of landfill waste.
INDUSTRY
Business Services
Sustainable Processes
IMPACT SECTOR
- In response to the COVID-19 pandemic, AeroSafe was selected to help deliver COVID-19 vaccines globally, owing to its outstanding cold chain capability to keep packages at -70˚C for several weeks
- 98%+ return rate on its durable and highly customizable shippers sustains the continued reuse of each shipper, reducing the impact on landfills
- AeroSafe has been proven to reduce biopharma product loss from temperature excursions by 20%, thereby ensuring product quality while delivering customer satisfaction
- AeroSafe’s mission is to improve patient lives by ensuring the safe, sustainable delivery and effective use of biopharma therapeutics. The company is committed to tackling the most pressing challenges in the global pharma supply chain industry by driving our growth through innovation and customer dedication.
Impact metrics tracked1
1As of June 2022. Metrics calculated and provided directly by the general partner or underlying company.
tons of CO2 reduced
(24,000 metrics tons)
26,500
789K
reused shipments, on track to exceed 1M in 2022
Shipments of COVID-19 vaccine, containing up to 670K doses
250K
Reduction in landfill waste
13K tons
Data provided directly by the general partner or underlying company.
Private Markets: Progress Made Possible
AeroSafe
Benevity
BetterNight
DigiCert
Climate Impact Partners
Imagine Learning
Ubicquia
Impact metrics tracked1
tons of CO2 reduced
(24,000 metrics tons)
26,500
789K
reused shipments, on track to exceed 1M in 2022
Reduction in landfill waste
13K tons
Data provided directly by the general partner or underlying company.
1As of June 2022. Metrics calculated and provided directly by the general partner or underlying company.
Shipments of COVID-19 vaccine, containing up to 670K doses
250K
- AeroSafe’s mission is to improve patient lives by ensuring the safe, sustainable delivery and effective use of biopharma therapeutics. The company is committed to tackling the most pressing challenges in the global pharma supply chain industry by driving our growth through innovation and customer dedication.
- In response to the COVID-19 pandemic, AeroSafe was selected to help deliver COVID-19 vaccines globally, owing to its outstanding cold chain capability to keep packages at -70˚C for several weeks
- 98%+ return rate on its durable and highly customizable shippers sustains the continued reuse of each shipper, reducing the impact on landfills
- AeroSafe has been proven to reduce biopharma product loss from temperature excursions by 20%, thereby ensuring product quality while delivering customer satisfaction
Sustainable Processes
IMPACT SECTOR
INDUSTRY
Business Services
With a unique business model built on reusable shippers and unmatched reverse logistics services, AeroSafe provides biopharma partners with hassle-free sustainable solutions to safely deliver their temperature-sensitive products, significantly reducing the amount of landfill waste.
